Abstract
(Am J Obstet Gynecol. 2023;228(4):478–479) Epidural analgesia is widely used and accepted as a safe and effective method for pain management during labor and delivery. Though there is substantial research supporting this, there is also concern that some drugs can cross the placenta into the fetal blood stream. The main concern is the transmission of opioids across the placenta to the fetus during labor and before birth, thereby resulting in residual effects after birth. This study aimed to examine the frequency with which newborns test positive for fentanyl in their urine after the use of epidural analgesia, as well as assess factors that increase the likelihood of a positive test and the association between fentanyl positivity and clinical outcomes for the newborn.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
